The Blood transfusion Genomics Consortium (BGC) is an international partnership between blood services, research institutions and industry leaders.
Our aim is to improve the safety and efficiency of blood and platelet transfusion by introducing cutting-edge genomics technology into routine clinical practice.
As the part of the BGC, the national blood services of Australia, Canada, England, Finland, the Netherlands, and South Africa together with the New York Blood Center work in partnership with academic hospitals in Boston and Cambridge, and Thermo Fisher Scientific to develop the DNA-based assays, software solutions, and infrastructure required to implement donor and patient genotyping at global scale.
The BGC has united several major blood services with leading academic hospitals and industry partners. Click below to find our more about our members!
Our primary focus is to improve transfusion care for donors and patients by developing and using cutting-edge genomics technologies. Click below to view our research plans!
We are committed to improving transfusion care for all people. If your organisation would like to join the BGC please click the link below to find our more!